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An alkylating ATP analogue, y-[4-(N-2-chlorethyl-N-methylamino)]henzylamide ATP (CIRATP), covalent- 
ly binds to the catalytic a-subunit of Na+,K+-ATPase yielding a product resistant to hydrolysis by the 
enzyme and inhibiting the ATP-hydrolysing activity. The Naf-form of the membrane-bound Na+,K+- 
ATPase modified with ClRATP was hydrolysed by pepsin under conditions providing maximum stability 
of the modification product (4°C pH 1 S). The modified peptide was isolated by HPLC and its amino acid 
sequence was found to involve residues 706713 of the a-subunit polypeptide chain. This fragment located 
near the y-phosphate of ATP is a component of the active site. It is highly homologous with corresponding 
regions of the catalytic subunits of all the known E,-E, ATPases. In the Na+-(or E,-)enzyme form Asp-710 
is the target of modification. Evidently E,- and E,-enzymes have different targets in ClRATP modification, 
i.e. the polypeptide chain regions near the ATP y-phosphate in the enzyme active site differ somewhat in 
their conformations. 
Na+,K+-ATPase; E,-conformation; Affinity modification; Catalytic site structure 
1. INTRODUCTION 
Na+,K+-ATPase is an integral membrane pro- 
tein providing a nonequilibrium distribution of 
sodium and potassium ions between the cell and 
medium coupled with the ATP hydrolysis. Ion- 
activators, Na+ and K+, regulate both the enzyme 
affinity for ATP [l] and the stability of the 
phosphorylated product whose formation is an in- 
termediate stage in the enzymatic hydrolysis of 
ATP [2]. Investigations of the active site 
topography for the enzyme in Er and E2 conforma- 
tions and especially the arrangement of the regions 
neighbouring ATP y-phosphate are indispensable 
for understanding the molecular mechanism of the 
enzyme function. However lack of information on 
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the primary structure of the enzyme subunits 
hindered such studies. The establishment of the 
primary structure [3-81 paved the way for research 
into the enzyme functioning at the molecular level 
and first of all into the topography of the 
Na+,K+-ATPase active site. 
The ATP derivative y-[4-(N-2-chlorethyl-N 
methylamino)]benzylamide ATP (CIRATP) is a 
functional analogue of ATP. We studied its in- 
teraction with Na+- and K+-enzyme forms [9]. The 
peptide including the 706-718 modification region 
of the a-subunit of the low-affinity K+-form was 
isolated. 
This paper describes the isolation of the CY- 
subunit fragment involving the ClRATP modifica- 
tion region of the high-affinity Na+-form of 
Na+,K+-ATPase. We determine the structure of 
this fragment, its position in the polypeptide chain, 
and location of the affinity reagent modification 
point. 
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2. MATERIALS AND METHODS 
Isolation of the homogeneous Na+,K+-ATPase 
preparation from pig kidney, determination of the 
enzyme activity, protein concentration, and amino 
acid composition were performed as in [lo]. 
The enzyme was modified with [‘4C]CIRATP, 
containing a labelled benzyl residue, in 20 mM 
Tris-HCI buffer (pH 7.5) at 37°C. Final concentra- 
tions of the protein and reagent were 5-7 mg/ml 
and 0.1-0.3 mM, respectively. To enhance the 
reagent incorporation, non-radioactive ClRATP 
was added once again in a 30 min interval up to a 
concentration of 1 mM. 
2.1. Pepsin hydrolysis 
A sample of membrane-bound Na+,K+-ATPase 
was resuspended in distilled water up to a protein 
concentration of lo-12 mg/ml. Pepsin dissolved 
in 10% acetic acid was added to the protein 
suspension, its volume being a half of the suspen- 
sion volume, pH of the mixture was adjusted to 1.5 
by HCl at 20°C the final pepsin concentration was 
1 mg/ml. After incubation of the mixture at 4°C 
for 48 h the membrane-bound protein was spun 
down by ultracentrifugation (a LS-50 Beckman in- 
strument, Austria, a SW-50.1 rotor, 2.5 h, 
40000 rpm/min). The supernatant was incubated 
at 4°C for 48 h, divided into portions corre- 
sponding to 7-8 mg of the original membrane- 
bound protein and frozen at -20°C. 
2.2. Isolation and sequencing of the modified 
peptide 
HPLC was performed on an LKB HPLC system 
(Sweden) equipped with pumps (model 2150), a 
variable wavelength monitor, model 2151, and 
Uvicord SD model 2158 flow-type spec- 
trophotometers. The hydrolysate was primarily 
separated on a 0.46 x 25 cm column with reverse- 
phase Bakerbond Wide-Pore Cl8 (J.T. Baker 
Research Products, USA) in 0.1% trifluoroacetic 
acid (TFA), triethylamine was added up to pH 2.5 
(buffer A), acetonitrile concentration gradient 
O-50% (the loading and flow rates 0.2 ml/min). 
The gradient profile is shown in fig.2. 
Rechromatography was carried out on a 
Milichrom microcolumn liquid-phase chromato- 
graph (reverse-phase Nucleosil 5Cls column 0.2 x 
6.4 cm) at pH 4.5 in 0.01 M sodium acetate and 
112 
then at pH 2.5 in buffer A; in both cases the step- 
wise acetonitrile gradient was used: step 1, 700 ~1 
of 1Ocrlo CHJCN in a corresponding buffer; step 2, 
700 ~1 of 20% solution; and step 3, 500 ~1 of 30% 
solution (flow rate 50fll/min, separation time 
20-30 min). The affinity-labelled peptide was 
identified by radioactivity and by the presence of 
the characteristic spectrum. 
The peptide primary structure was determined 
either by automated degradation on an Applied 
Biosystems model 470A gas-phase sequenator 
(phenylhydantoins identified by HPLC) or by the 
manual dansyl-Edman procedure. 
To synthesise the model compound 200,ul of 
3 M CHsCOONa (pH 5.5) were added to 4.25 
mg of 4-(N-2-chloroethyl-N-methylamino)benzyla- 
mine (ClR) and incubated for 1 h at 56°C. The 
product was extracted and stored in butanol. (The 
model compound and peptides were treated with 
1 M NHdOH, pH 10, at 20°C for 48 h to hydrolyse 
the ester bond.) 
3. RESULTS AND DISCUSSION 
The peptide containing covalently and 
specifically bound ClRATP in the El-form of the 
enzyme was isolated from pig kidney 
Na+,K+-ATPase modified with ClRATP in the 
presence of sodium ions. Fig.1 shows that the 
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Fig.1. Dependence of inactivation of Na+,K+-ATPase 
on ClRATP concentration i the presence of 150 mM 
NaCl (O), 150 mM KC1 (A), 150 mM NaCl and 10 mM 
ATP (0). The reaction mixture was incubated for 
30 min at 37°C. 
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Na+-enzyme (0) form is completely inactivated at 
considerably smaller reagent concentrations than 
its K+-form (A), ATP effectively protects the en- 
zyme from inactivation (0). At first we applied a 
technique for the differential modification [9] to 
affect the active site selectively, but now the pro- 
tein is modified directly with [‘4C]ClRATP since 
the level of unspecific insertion is low in the intact 
protein and peptide material: after separation of 
the pepsin hydrolysate, a main radioactivity peak 
was registered and corresponded to the fraction 
with the absorption maximum at 260 nm. 
The incorporated reagent remained unchanged 
and inactivation of the enzyme was irreversible for 
at least 1 month if the protein was stored at 4”C, 
pH 7.2. The labelled modified protein was washed 
many times by ultracentrifugation or immobiliza- 
tion on filters [ll]; still the amount of inserted 
label was the same, i.e. the covalent bonding inside 
the enzyme is rather strong. However, after 
denaturation of the modified protein in the 
presence of SDS the reagent-protein bond ap- 
peared to be thermo- and baselabile as in the case 
of the K+-enzyme. After solubilization of the pro- 
tein with 1% SDS at 100°C for 3 min, the major 
portion of the label was bound to the protein only 
at pH 2.0; at pH 9.0 such a short denaturation time 
liberated 70% of the original amount of the bound 
[14C]C1RATP (not shown; measurements were car- 
ried out as in [9]). The ‘Na+-protein’ was hydro- 
lysed with pepsin at pH 1.5, 4°C (see section 2), 
i.e. under the conditions described in [9]. The con- 
ditions were chosen judging from characteristics of 
the reagent-protein covalent bond (thermolability 
and resistance to acids) and from comparison of 
the results obtained for the modified ‘K+-protein’. 
O- 
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Fig.2. Separation of peptides from the pepsin hydrolysate and distribution of radioactivity along the column 0.46 x 
25 cm (support Bakerbond Wide Pore CI~). Eluting buffers: A, 0.1% TFA, triethylamine was added up to pH 2.5; B, 
50% CHsCN in buffer A. Flow rate 0.2 ml/min, upwards: A, absorbance at280 nm; B, at 254 nm; broken line, change 
in per cent content of buffer B. The height of columns (C) corresponds to radioactivity of the fraction. The fraction 
subjected to further chromatography is hatched. 
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The peptide was isolated from the pepsin 
hydrolysate by HPLC on a Bakerbond Wide Pore 
C18 column, then detected by absorbance (at A 260 
and 280 nm) and radioactivity measurements. One 
should note that ATP cleaves from the ClRATP 
molecule because of instability of the phospho- 
amide bond in the acidic medium. CIR bound to 
the protein has an absorption maximum at 260 nm 
and f = 10000. The fraction with the absorption 
ratio Az~o/Az~o > 1 was rechromatographed at two 
different pH values by microcolumn HPLC to 
decrease irreversible sorption. It contained the 
largest amount of radioactive label (fig.2). The 
peptide obtained (fig.3) differed from the earlier 
isolated K+-peptide in length (from ratio 
&O/&60) and in retention time. 
Thermo- and baselability indicate the ester 
bonding of the protein and reagent. To prove this 
suggestion the model compound (ester of GlR and 
acetic acid) was synthesised. Under conditions 
chosen for its complete hydrolysis (1 M NHdOH, 
pH 10, 20°C) the label was fully removed from 
both Na+- and K+-peptides for 48 h. In the acidic 
medium the bond was stable. In such a way the 
A210 
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protein-reagent linkage via the covalent ester bond 
was confirmed. 
The structure of the isolated peptide was 
established by two ways: (i) the label was removed 
and the peptide was sequenced by the dansyl- 
Edman method that gave Asx at the fifth step; (ii) 
the labelled peptide was analysed on a gas-phase 
sequenator that resulted at the fifth step in a 
derivative of the amino acid residue differing in 
chromatographic characteristics as compared to 
known amino acids. Deciphering the complete 
peptide structure allowed us to identify it as the 
fragment of the polypeptide chain of the catalytic 
a-subunit with coordinates Ala-706-Ala-7 13. 
Spectral (fig.3) and sequencing data, lack of 
aromatic amino acid residues in the peptide struc- 
ture, ester bonding of the reagent and protein pro- 
vide evidence that the isolated peptide is modified 
and consequently represents a component of the 
enzyme active site. The Asp-710 residue is a target, 
whose modification with CIRATP causes the com- 
plete loss of the enzyme activity. 
Comparison of the amino acid sequence of this 
peptide and the corresponding regions of the cy- 
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Fig.3. Final stage of purification of the fraction denoted in fig.2 and absorption spectrum of the homogeneous modified 
peptide. Column, 0.2 x 6.4 cm; support, Nucleosil SC 18. Flow rate, 50plImin. Dark contour, absorbance at 210 nm; 
light contour, at 260 nm. Stepwise gradient of acetonitrile (700~1 of 10% CH$N, 700,~l of 20% CHsCN, 500~1 of 
30% CH$N) in 0.01 M CH3COONa (pH 4.5) was used. 
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Table 1 
Comparison of amino acid sequences of the modified peptide and 
corresponding regions of other El-E2 ATPases 
ATPase Amino acid sequence 
Na+,K+-ATPase 131 706Ala-Val-Thr-Gly-Asp-Gly-Val-Asn713 
Ca2+-ATPase [ 141 698Ala-Met-Thr-Gly-Asp-Gly-Val-Asn70s 
Kdp-ATPase [ 151 512Ala-Met-Thr-Gly-Asp-Gly-Thr-Asns19 
H+-ATPase [
E. coli 
[ 151, H+-ATPase from the yeast plasma membrane 
[16] and plasma membrane of Neurospora crassa 
[17], shows the high sequence homology of these 
fragments (table 1). The Asp-710 residue is iden- 
tical in all the structures mentioned above. The 
homology region including the isolated peptide is 
rather extended: it embraces also the fragment of 
the polypeptide chain modified with 5 ‘-(p- 
fluorosulfonyl)benzoyladenosine [ 181. Here Lys, 
being a modification target, is invariant in all the 
mentioned ATPases except for Kdp-ATPase of E. 
coli [ 151. This region begins from Phe-683 and in- 
volves the fragment previously identified as a com- 
ponent with a low-affinity active site for binding 
ClRATP in the K+-form of the enzyme [9]. This 
fragment contains two invariant Asp residues for 
all the structures of the transport ATPases listed in 
table 1. Each of them can be a target for modifica- 
tion of the enzyme in the K+-form, at present we 
try to localise the points of modification. Pepsin 
hydrolyses of the a-subunit of Na+,K+-ATPase 
modified with ClRATP in the K+-form, and in the 
Na+-form produce different peptides. In the case 
of the K+-form the modified peptide is longer and 
includes the second Asp residue and suggests that 
Asp-714 is the modified residue. Binding of K+ or 
Na+ stabilises the enzyme in EI or EZ conforma- 
tions, respectively, and influences the enzyme af- 
finity for ATP. It can induce small translocations 
of the polypeptide chain around the y-phosphate 
binding site in such a way that spatially separated 
residues Asp-710 or Asp-714 become the target of 
modification with affinity reagent CIRATP. 
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